大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/06 | 6,608 | 6,629 | 6,417 | 6,463 | -104 | -1.6% | 1,196,100 |
| 2024/06/05 | 6,447 | 6,590 | 6,432 | 6,567 | +104 | +1.6% | 976,300 |
| 2024/06/04 | 6,383 | 6,465 | 6,371 | 6,463 | -19 | -0.3% | 888,900 |
| 2024/06/03 | 6,498 | 6,577 | 6,452 | 6,482 | +8 | +0.1% | 855,200 |
| 2024/05/31 | 6,206 | 6,485 | 6,190 | 6,474 | +218 | +3.5% | 3,029,000 |
| 2024/05/30 | 6,132 | 6,256 | 6,079 | 6,256 | +154 | +2.5% | 1,140,000 |
| 2024/05/29 | 6,105 | 6,154 | 6,080 | 6,102 | -50 | -0.8% | 770,400 |
| 2024/05/28 | 6,164 | 6,208 | 6,124 | 6,152 | ±0 | ±0% | 669,000 |
| 2024/05/27 | 6,184 | 6,184 | 6,075 | 6,152 | -32 | -0.5% | 543,600 |
| 2024/05/24 | 6,101 | 6,252 | 6,088 | 6,184 | -46 | -0.7% | 864,900 |
| 2024/05/23 | 6,283 | 6,344 | 6,176 | 6,230 | -121 | -1.9% | 1,954,800 |
| 2024/05/22 | 6,444 | 6,444 | 6,346 | 6,351 | -113 | -1.7% | 697,900 |
| 2024/05/21 | 6,521 | 6,546 | 6,457 | 6,464 | -41 | -0.6% | 515,200 |
| 2024/05/20 | 6,470 | 6,588 | 6,465 | 6,505 | -2 | ±0% | 775,300 |
| 2024/05/17 | 6,455 | 6,544 | 6,455 | 6,507 | -81 | -1.2% | 873,500 |
| 2024/05/16 | 6,590 | 6,641 | 6,558 | 6,588 | -2 | ±0% | 768,800 |
| 2024/05/15 | 6,652 | 6,708 | 6,558 | 6,590 | -51 | -0.8% | 982,200 |
| 2024/05/14 | 6,599 | 6,707 | 6,568 | 6,641 | +15 | +0.2% | 1,020,500 |
| 2024/05/13 | 6,536 | 6,660 | 6,534 | 6,626 | +40 | +0.6% | 880,900 |
| 2024/05/10 | 6,493 | 6,595 | 6,493 | 6,586 | +134 | +2.1% | 1,027,600 |
| 2024/05/09 | 6,401 | 6,473 | 6,342 | 6,452 | +68 | +1.1% | 739,100 |
| 2024/05/08 | 6,478 | 6,478 | 6,319 | 6,384 | -80 | -1.2% | 1,013,100 |
| 2024/05/07 | 6,377 | 6,473 | 6,356 | 6,464 | +82 | +1.3% | 1,206,600 |
| 2024/05/02 | 6,478 | 6,499 | 6,342 | 6,382 | -179 | -2.7% | 1,270,800 |
| 2024/05/01 | 6,744 | 6,845 | 6,541 | 6,561 | -181 | -2.7% | 1,467,500 |
| 2024/04/30 | 6,530 | 6,742 | 6,373 | 6,742 | +372 | +5.8% | 2,201,400 |
| 2024/04/26 | 6,245 | 6,393 | 6,218 | 6,370 | +98 | +1.6% | 919,100 |
| 2024/04/25 | 6,358 | 6,378 | 6,260 | 6,272 | -86 | -1.4% | 871,000 |
| 2024/04/24 | 6,359 | 6,383 | 6,307 | 6,358 | +18 | +0.3% | 971,800 |
| 2024/04/23 | 6,342 | 6,408 | 6,324 | 6,340 | +18 | +0.3% | 653,300 |
| 2024/04/22 | 6,286 | 6,347 | 6,221 | 6,322 | +136 | +2.2% | 706,700 |
| 2024/04/19 | 6,160 | 6,210 | 6,066 | 6,186 | -8 | -0.1% | 1,008,800 |
| 2024/04/18 | 6,239 | 6,292 | 6,186 | 6,194 | -67 | -1.1% | 777,700 |
| 2024/04/17 | 6,301 | 6,329 | 6,256 | 6,261 | -75 | -1.2% | 643,400 |
| 2024/04/16 | 6,301 | 6,360 | 6,257 | 6,336 | -10 | -0.2% | 921,200 |
| 2024/04/15 | 6,300 | 6,391 | 6,270 | 6,346 | -40 | -0.6% | 688,400 |
| 2024/04/12 | 6,392 | 6,415 | 6,311 | 6,386 | +81 | +1.3% | 1,036,400 |
| 2024/04/11 | 6,250 | 6,314 | 6,205 | 6,305 | -23 | -0.4% | 961,900 |
| 2024/04/10 | 6,363 | 6,386 | 6,304 | 6,328 | +65 | +1% | 837,600 |
| 2024/04/09 | 6,250 | 6,282 | 6,204 | 6,263 | -6 | -0.1% | 615,100 |
| 2024/04/08 | 6,230 | 6,306 | 6,224 | 6,269 | +51 | +0.8% | 834,800 |
| 2024/04/05 | 6,220 | 6,245 | 6,137 | 6,218 | -98 | -1.6% | 1,335,900 |
| 2024/04/04 | 6,350 | 6,398 | 6,294 | 6,316 | -33 | -0.5% | 1,109,200 |
| 2024/04/03 | 6,369 | 6,408 | 6,283 | 6,349 | -21 | -0.3% | 1,358,300 |
| 2024/04/02 | 6,368 | 6,430 | 6,329 | 6,370 | +37 | +0.6% | 1,181,300 |
| 2024/04/01 | 6,324 | 6,373 | 6,275 | 6,333 | +23 | +0.4% | 557,500 |
| 2024/03/29 | 6,315 | 6,329 | 6,248 | 6,310 | +39 | +0.6% | 1,107,900 |
| 2024/03/28 | 6,379 | 6,414 | 6,251 | 6,271 | -111 | -1.7% | 1,106,800 |
| 2024/03/27 | 6,300 | 6,418 | 6,290 | 6,382 | +93 | +1.5% | 1,197,500 |
| 2024/03/26 | 6,262 | 6,312 | 6,212 | 6,289 | -29 | -0.5% | 764,300 |
251～
300
件表示中 / 3547件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 719,100円 | +2.2% | +10.2% | 1.67% | 13.81倍 | 1.39倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 武 田 | 434,500円 | -1.1% | +75.3% | 4.60% | 29.76倍 | 0.98倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 345,200円 | +6.0% | +4.0% | 2.26% | 21.43倍 | 3.96倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| アステラス薬 | 138,300円 | +0.9% | +380.2% | 5.64% | 19.05倍 | 1.64倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 249,600円 | +20.9% | +10.6% | 2.64% | 11.80倍 | 1.56倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
